Stiftung Kantonsspital Graubünden
- Sector unverified
- Rank 326 / 334
Stiftung Kantonsspital Graubünden is recorded by Swissmedic as the authorisation holder for 1 human medicine, which places it 326 of 334 authorisation holders. Its portfolio is mostly in the Transplantat: Zelltherapieprodukt category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 1 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
No medicine authorisation
Stiftung Kantonsspital Graubünden is not recorded as an authorisation holder for human medicines with Swissmedic. That is normal for device manufacturers, contract manufacturers, wholesalers, laboratories and consultancies.
Authorisation holders recorded by Swissmedic whose business model we have not researched. The Swissmedic list carries no sector field, so we assign these companies to none.
Frequently asked questions
How many medicines does Stiftung Kantonsspital Graubünden have authorised in Switzerland?
Stiftung Kantonsspital Graubünden is recorded by Swissmedic as the authorisation holder for 1 human medicine (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Stiftung Kantonsspital Graubünden based?
We have no confirmed Swiss address for Stiftung Kantonsspital Graubünden. We add it as soon as the commercial register or the company confirms it.
Is Stiftung Kantonsspital Graubünden a Swissmedic authorisation holder?
Yes. Stiftung Kantonsspital Graubünden appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.